Stanford Medicine
Linda Avey is the Co-Founder and CEO of Precise.ly, a personal health platform designed to close the information gap between health experts and consumers. By matching research and clinical insights to specific genetic markers, Precise.ly delivers targeted information to individuals, with the mission of expediting the translation of relevant medical knowledge and facilitating Precision Health.
In 2006, Linda pioneered the field of consumer genetics with the co-founding of 23andMe, a leading personal genetic testing service. Previously, she spent 20 years in sales and business development in the biomolecular research industry. She helped develop genetics research programs for Affymetrix and Perlegen Sciences, leading to the first genome-wide association study of Parkinson's disease.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Stanford Medicine
Stanford Medicine improves health through leadership, diversity, and collaborative discoveries and innovation in health care, education, and research. The Stanford School of Medicine is a premier setting for integrated research, medical education, and clinical care. As the academic hub of Stanford Medicine, which also comprises adult and pediatric healthcare delivery systems, it fuels discovery and innovation to advance human health while empowering the medical and scientific leaders of tomorrow. Learn more at med.stanford.edu/school.